Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection

Qingqing Lin, Zhu Li, Zuowei Ni, +2

Journal of Microbiology Immunology and Infection

Viral PersistenceImmunologySerologic TestingVirologyCovid-19 +2

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Huafeng Wang, Liping Mao, Min Yang, +21

The Lancet Haematology

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid Neoplasia +8

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

Hongyan Tong, Yanling Ren, Hui Liu, +10

Leukemia & lymphoma/Leukemia and lymphoma

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia

Yin Tong, Liangshun You, Hui Liu, +4

Oncotarget

ApoptosisImmunologyCell DeathImmunotherapyCancer Biology +16

Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy

Yinjun Lou, Yafang Ma, Shanshan Suo, +12

Leukemia Research

Prognostic FactorsHematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder +6

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Yinjun Lou, Yafang Ma, Jianai Sun, +9

Annals of Hematology

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology +7

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Jin Jie, Siguo Hao, Songfu Jiang, +17

Blood

High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia

Qitian Mu, Yungui Wang, Bing Chen, +8

Leukemia Research

Hematological MalignancyTumor BiologyMedicineMalignant Blood DisorderMixed-phenotype Acute Leukemia +8

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience

Wenjuan Yu, Liping Mao, Jiejing Qian, +6

Annals of Hematology

Hematological MalignancyMedicinal ChemistryMedicineMixed-phenotype Acute LeukemiaHematology +5

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Siguo Hao, Jie Jin, Songfu Jiang, +17

Blood